These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 1319864)

  • 1. Temafloxacin: the pharmacokinetic profile of a new quinolone. A seminar-in-print.
    Clin Pharmacokinet; 1992; 22 Suppl 1():1-107. PubMed ID: 1319864
    [No Abstract]   [Full Text] [Related]  

  • 2. Biliary elimination and hepatic disposition of a new fluoroquinolone, temafloxacin: experimental evaluation.
    Brogard JM; Koechlin C; Westphal JF; Blicklé JF; Dorner M; Jehl F
    Drugs Exp Clin Res; 1990; 16(8):407-16. PubMed ID: 2097145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic studies in rats with ofloxacin and MF-934, a new fluorinated quinolone.
    Mattina R; Bellotti M; Raimondi A; Sander K
    Chemioterapia; 1987 Jun; 6(2 Suppl):302-3. PubMed ID: 3334569
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of food on the bioavailability of temafloxacin. A review of 3 studies.
    Granneman GR; Mukherjee D
    Clin Pharmacokinet; 1992; 22 Suppl 1():48-56. PubMed ID: 1319871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developmental toxicity of fleroxacin and comparative pharmacokinetics of four fluoroquinolones in the cynomolgus macaque (Macaca fascicularis).
    Hummler H; Richter WF; Hendrickx AG
    Toxicol Appl Pharmacol; 1993 Sep; 122(1):34-45. PubMed ID: 8397453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic study of danofloxacin in cattle and swine.
    Mann DD; Frame GM
    Am J Vet Res; 1992 Jun; 53(6):1022-6. PubMed ID: 1320812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative pharmacokinetics of ciprofloxacin and temafloxacin in humans: a review.
    Sorgel F; Naber KG; Kinzig M; Mahr G; Muth P
    Am J Med; 1991 Dec; 91(6A):51S-66S. PubMed ID: 1662896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of the pharmacokinetic profile of temafloxacin.
    Dudley MN
    J Antimicrob Chemother; 1991 Dec; 28 Suppl C():55-64. PubMed ID: 1664830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cimetidine on the pharmacokinetics of temafloxacin.
    Sörgel F; Granneman GR; Stephan U; Locke C
    Clin Pharmacokinet; 1992; 22 Suppl 1():75-82. PubMed ID: 1319874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lomefloxacin and temafloxacin: two new fluoroquinolone antimicrobials.
    Symonds WT; Nix DE
    Clin Pharm; 1992 Sep; 11(9):753-66. PubMed ID: 1325892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temafloxacin: a safe antibiotic for the elderly, patients with comorbidities, and other special populations.
    Pernet AG
    Am J Med; 1991 Dec; 91(6A):162S-165S. PubMed ID: 1662888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative pharmacokinetic disposition of fluoroquinolones in the lung.
    Wise R; Baldwin DR; Andrews JM; Honeybourne D
    J Antimicrob Chemother; 1991 Dec; 28 Suppl C():65-71. PubMed ID: 1664831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic disposition of temafloxacin and ciprofloxacin in a murine model of pneumococcal pneumonia. Relevance for drug efficacy.
    Vallée E; Azoulay-Dupuis E; Bauchet J; Pocidalo JJ
    J Pharmacol Exp Ther; 1992 Sep; 262(3):1203-8. PubMed ID: 1326627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental study on the hepatobiliary kinetics and excretion of temafloxacin. Evidence for production of active metabolites by the rabbit liver].
    Brogard JM; Westphal JF; Koechlin C; Jehl F; Dorner M; Blickle JF; Monteil H
    Pathol Biol (Paris); 1991 May; 39(5):524-9. PubMed ID: 1881688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penetration of temafloxacin into body tissues and fluids.
    Sörgel F
    Clin Pharmacokinet; 1992; 22 Suppl 1():57-63. PubMed ID: 1319872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Renal clearance of rufloxacin in the healthy volunteer].
    Segre G; Cerretani D; Moltoni L; Urso R
    G Ital Chemioter; 1991; 38(1-3):123-6. PubMed ID: 1365563
    [No Abstract]   [Full Text] [Related]  

  • 17. Olamufloxacin. Hokuriku Seiyaku.
    Jiraskova N
    Curr Opin Investig Drugs; 2000 Sep; 1(1):31-4. PubMed ID: 11249592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic study of a new quinolone, DW-116.
    Lee DK
    Drugs; 1995; 49 Suppl 2():323-5. PubMed ID: 8549349
    [No Abstract]   [Full Text] [Related]  

  • 19. ESGAB breakpoint determination: temafloxacin.
    Phillips I; Acar J; Baquero F; Bergan T; Forsgren A; Wiedemann B
    Eur J Clin Microbiol Infect Dis; 1991 Nov; 10(11):991-2. PubMed ID: 1665417
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetic and residue studies of quinolone compounds and olaquindox in poultry.
    Anadón A; Martinez-Larrañaga MR; Diaz MJ; Velez C; Bringas P
    Ann Rech Vet; 1990; 21 Suppl 1():137S-144S. PubMed ID: 2080842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.